Federal Register / Vol. 74, No. 98 / Friday, May 22, 2009 / Notices 24021 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): CDC Grants for 

Public Health Research Dissertation, 

Panel H, Funding Opportunity 

Announcement (FOA) PAR07–231, 

Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the aforementioned meeting. 

Time and Date: 12:30 p.m.–4:30 p.m., 

June 11, 2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Sections 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters to be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘CDC Grants for Public Health Research 

Dissertation, Panel H, FOA PAR07– 

231.’’ 

Contact Person for more Information: 

Maurine F. Goodman, M.A., M.P.H., 

Scientific Review Officer, Office of the 

Director, Office of the Chief Science 

Officer, CDC, 1600 Clifton Road, NE., 

Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–4737. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 14, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12001 Filed 5–21–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Refugee Resettlement 

Notice of a Noncompetitive Successor 

Award to Center for Community 

Development for New Americans Grant 

Number 90RG0068 

AGENCY: Office of Refugee Resettlement, 

ACF, HHS. 

ACTION: Notice of a Noncompetitive 

Successor Award to Center for 

Community Development for New 

Americans Grant Number 90RG0068. 

CDFA#: 93.576. 

Legislative Authority: Section 

412(c)(1)(A) of the Immigration and 

Nationality Act (INA) 8 U.S.C. 

1522(c)(1)(A) authorizes the ORR 

Director ‘‘to make grants to, and enter 

into contracts with, public or private 

nonprofit agencies for projects 

specifically designed—(i) To assist 

refugees in obtaining the skills which 

are necessary for economic selfsufficiency, including projects for job 

training, employment services, day care, 

professional refresher training, and 

other recertification services; (ii) to 

provide training in English where 

necessary (regardless of whether the 

refugees are employed or receiving cash 

or other assistance); and (iii) to provide 

where specific needs have been shown 

and recognized by the Director, health 

(including mental health) services, 

social services, educational and other 

services.’’ In addition, section 

412(a)(4)(A)(i) of the INA 8 U.S.C. 

1522(a)(4)(A)(i) authorizes the Director 

to make loans for the purpose of 

carrying out this section. 

Amount of Award: Remainder of 

current budget period February 1, 2009, 

through September 29, 2009, award is 

$261,356; final budget period of the 

originally approved five-year project 

period through September 29, 2012; 

Annual Amount $300,000. 

Projected Period: February 1, 2009– 

September 29, 2012. 

SUMMARY: In FY 2007, ORR awarded a 

competitive service grant for the 

Microenterprise Development Program 

grant to New York Association for New 

Americans, Inc. (NYANA) in New York, 

New York. The original project was 

from September 29, 2007, through 

September 30, 2012. NYANA served as 

the fiscal sponsor and legal entity of the 

approved project. As of February 1, 

2009, NYANA has ceased operations of 

the Microenterprise Development 

Program. NYANA has requested ORR 

permission for the Center for 

Community Development for New 

Americans (CCDNA) to assume the 

grant. CCDNA has agreed to this request. 

The effect of this deviation request is to 

transfer the grant from the initial grantee 

to a new grantee with all the 

responsibilities of managing and 

implementing the project for the 

remainder of the grant period. 

Contact Information: Ronald Munia, 

Director, Division of Community 

Resettlement, Office of Refugee 

Resettlement, 370 L’Enfant Promenade, 

SW., Washington, DC 20447. Telephone 

(202) 401–4559. E-mail: 

Ronald.munia@acf.hhs.gov. 

Dated: April 30, 2009. 

Ronald Munia, 

Director, Division of Community 

Resettlement, Office of Refugee Resettlement. 

[FR Doc. E9–11963 Filed 5–21–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Refugee Resettlement 

AGENCY: Office of Refugee Resettlement, 

ACF, HHS. 

ACTION: Notice of a Noncompetitive 

Successor Award to Center for 

Community Development for New 

Americans Grant Number 90Z10057. 

CDFA#: 93.576. 

Legislative Authority: Section 

412(c)(1)(A) of the Immigration and 

Nationality Act (INA) 8 U.S.C. 

1522(c)(1)(A) authorizes the ORR 

Director ‘‘to make grants to, and enter 

into contracts with, public or private 

nonprofit agencies for projects 

specifically designed—(i) To assist 

refugees in obtaining the skills which 

are necessary for economic selfsufficiency, including projects for job 

training, employment services, day care, 

professional refresher training, and 

other recertification services; (ii) to 

provide training in English where 

necessary (regardless of whether the 

refugees are employed or receiving cash 

or other assistance, and (iii) to provide 

where specific needs have been shown 

and recognized by the Director, health 

(including mental health) services, 

social services, educational and other 

services.’’ In addition, section 

412(a)(4)(A)(i) of the INA 8 U.S.C. 

1522(a)(4)(A)(i) authorizes the Director 

to make loans for the purpose of 

carrying out this section. 


erowe on PROD1PC63 with NOTICES
24022 Federal Register / Vol. 74, No. 98 / Friday, May 22, 2009 / Notices 

Amount of Award: Remainder of 

current budget period February 1, 2009, 

through September 29, 2009; Award is 

$286,458. Final budget period of the 

originally approved five-year project 

period through September 29, 2010; 

Annual Amount $300,000. 

Projected Period: February 1, 2009– 

September 29, 2010. 

SUMMARY: In FY 2005, ORR awarded a 

competitive service grant for the 

Individual Development Account (IDA) 

Program grant to New York Association 

for New Americans, Inc. (NYANA) in 

New York, NY. The original project was 

from September 29, 2005, through 

September 30, 2010. NYANA served as 

the fiscal sponsor and legal entity of the 

approved project. As of February 1, 

2009, NYANA has ceased operations of 

the Individual Development Account 

program. NYANA has requested ORR 

permission for the Center for 

Community Development for New 

Americans (CCDNA) to assume the 

grant. CCDNA has agreed to this request. 

The effect of this deviation request is to 

transfer the grant from the initial grantee 

to a new grantee with all the 

responsibilities of managing and 

implementing the project for the 

remainder of the grant period. 

Contact Information: Ronald Munia, 

Director, Division of Community 

Resettlement, Office of Refugee 

Resettlement, 370 L’Enfant Promenade, 

SW., Washington, DC 20447. Telephone 

(202) 401–4559. E-mail: 

Ronald.munia@acf.hhs.gov. 

Dated: April 30, 2009. 

Ronald Munia, 

Director, Division of Community 

Resettlement, Office of Refugee Resettlement. 

[FR Doc. E9–11961 Filed 5–21–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Food and Drug Administration Clinical 

Trial Requirements; Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

SUMMARY: The Food and Drug 

Administration (FDA) Minneapolis 

District, in cosponsorship with the 

Society of Clinical Research Associates, 

Inc. (SoCRA) is announcing a public 

workshop entitled ‘‘FDA Clinical Trial 

Requirements.’’ This 2-day public 

workshop is intended to provide 

information about FDA clinical trial 

requirements to the regulated industry. 

Date and Time: The public workshop 

will be held on Wednesday, June 10, 

2009, from 8:30 a.m. to 5 p.m., and 

Thursday, June 11, 2009, from 8:30 a.m. 

to 5 p.m. 

Location: The public workshop will 

be held at the Radisson University 

Hotel, Suite 600, 615 Washington Ave., 

SE., Minneapolis, MN 55414, 612–379– 

8888 or 1–800–822–6757 or 888–201– 

1718. 

Contact: Carrie Hoffman, Food and 

Drug Administration, 250 Marquette 

Ave., Minneapolis, MN 55401, 612– 

758–7200, FAX: 612–334–4142, e-mail: 

carrie.hoffman@fda.hhs.gov. 

Attendees are responsible for their 

own accommodations. To make 

reservations at the Radisson University 

Hotel, contact the Radisson University 

Hotel (see Location). 

Registration: You are encouraged to 

register by June 9, 2009. The SoCRA 

registration fees cover the cost of 

facilities, materials, and breaks. Seats 

are limited; please submit your 

registration as soon as possible. Course 

space will be filled in order of receipt 

of registration. Those accepted into the 

course will receive confirmation. 

Registration will close after the course is 

filled. Registration at the site is not 

guaranteed but may be possible on a 

space available basis on the day of the 

public workshop beginning at 8 a.m. 

The cost of registration is as follows: 

FDA employee (fee waived), 

Government employee nonmember 

($525), non-Government employee 

SoCRA member ($575), nonGovernment employee non-SoCRA 

member ($650). 

If you need special accommodations 

due to a disability, please contact Carrie 

Hoffman (see Contact) at least 7 days in 

advance of the workshop. 

Registration Instructions: To register, 

please submit a registration form with 

your name, affiliation, mailing address, 

phone, fax number, and e-mail, along 

with a check or money order payable to 

‘‘SoCRA.’’ Mail to: SoCRA, 530 West 

Butler Ave., Suite 109, Chalfont, PA 

18914. To register via the Internet, go to 

http://www.socra.org/html/ 

FDA_Conference.htm. (FDA has verified 

the Web site address, but we are not 

responsible for any subsequent changes 

to the Web site after this document 

publishes in the Federal Register.) 

The registrar will also accept payment 

by major credit cards (VISA/ 

MasterCard/AMEX only). For more 

information on the meeting, or for 

questions on registration, contact 

SoCRA at 800–762–7292 or 215–822– 

8644, FAX: 215–822–8633, or e-mail: 

SoCRAmail@aol.com. 

SUPPLEMENTARY INFORMATION: The 

public workshop helps fulfill the 

Department of Health and Human 

Services’ and FDA’s important mission 

to protect the public health. Topics for 

discussion include the following: (1) 

What FDA Expects in a Pharmaceutical 

Clinical Trial; (2) Adverse Event 

Reporting—Science, Regulation, Error 

and Safety; (3) Part 11 Compliance— 

Electronic Signatures; (4) Informed 

Consent Regulations; (5) IRB 

Regulations and FDA Inspections; (6) 

Keeping Informed and Working 

Together; (7) FDA Conduct of Clinical 

Investigator Inspections; (8) Meetings 

with FDA: Why, When, and How; (9) 

Investigator Initiated Research; (10) 

Medical Device Aspects of Clinical 

Research; (11) Working with FDA’s 

Center for Biologics Evaluation and 

Research; (12) The Inspection is Over— 

What Happens Next? Possible FDA 

Compliance Actions. 

FDA has made education of the drug 

and device manufacturing community a 

high priority to help ensure the quality 

of FDA-regulated drugs and devices. 

The workshop helps to achieve 

objectives set forth in section 406 of the 

FDA Modernization Act of 1997 (21 

U.S.C. 393) which includes working 

closely with stakeholders and 

maximizing the availability and clarity 

of information to stakeholders and the 

public. The workshop also is consistent 

with the Small Business Regulatory 

Enforcement Fairness Act of 1996 (Pub. 

L. 104–121), as outreach activities by 

Government agencies to small 

businesses. 

Dated: May 18, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–12051 Filed 5–21–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HOMELAND 

SECURITY 

Office of the Secretary 

[Docket No. DHS–2009–0015] 

Privacy Act of 1974; United States 

Citizenship Immigration Services 009 

Compliance Tracking and Monitoring 

System; System of Records 

AGENCY: Privacy Office, DHS. 

ACTION: Notice of Privacy Act system of 

records. 

SUMMARY: In accordance with the 

Privacy Act of 1974 the Department of 


erowe on PROD1PC63 with NOTICES